Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03759834 · ClinicalTrials.gov registry record · NA
Cochlear Promontory Stimulation for Treatment of Tinnitus
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03759834: Completed NA study, sponsored by Mayo Clinic.
NCT03759834 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03759834, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Tinnitus is the perception of sound when no external noise is present. The Center for Disease Control (CDC) estimates over 50 million - nearly 15% of the general public -experience some form of tinnitus. Roughly 20 million people struggle with burdensome chronic tinnitus, with 2 million experiencing extreme and debilitating symptoms. The 2014 Clinical Practice Guideline on tinnitus from the American Academy of Otolaryngology - Head and Neck Surgery summarized the existing state of tinnitus management by stating "A cure for primary tinnitus does not yet exist, and despite claims to the contrary, no method has been proven to provide long-term suppression of tinnitus." The purpose of this study is to look at the safety and efficacy of cochlear promontory stimulation in the short term relief of tinnitus. The secondary goal of the study is to determine the optimum region(s) of the cochlear promontory in planning for an implantable electrical device for long term tinnitus suppression.
Interventions
- DEVICE Cochlear promontory stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-01-04 |
| Est. Completion | 2024-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03759834
The ClinicalTrials.gov registry entry for NCT03759834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cochlear promontory stimulation is the first listed.
NCT03759834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03759834 about?
NCT03759834 is a clinical study titled "Cochlear Promontory Stimulation for Treatment of Tinnitus". Tinnitus is the perception of sound when no external noise is present. The Center for Disease Control (CDC) estimates over 50 million - nearly 15% of the general public -experience some form of tinnitus. Roughly 20 million people struggle with burdensome chronic tinnitus, with 2 million experiencing...
What is the current status of trial NCT03759834?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-01-04. Estimated completion is 2024-08-13.
What interventions are being tested in trial NCT03759834?
The interventions under investigation include: Cochlear promontory stimulation (DEVICE).
Who is sponsoring clinical trial NCT03759834?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.